Enteropathy-type (intestinal) T-cell lymphoma not remission is a rare and aggressive form of lymphoma characterized by the proliferation of T-cells in the intestinal mucosa. It is often associated with chronic gastrointestinal conditions, particularly celiac disease. Accurate coding with ICD-10 Code C86.20 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this serious condition effectively.
ICD-10 Code C86.20 represents Enteropathy-type (intestinal) T-cell lymphoma not remission, a malignancy of T-cells that typically arises in the context of chronic enteropathy. This code should be used when documenting cases where the lymphoma is active and not in remission, facilitating appropriate clinical management and billing for treatment services.
Enteropathy-type (intestinal) T-cell lymphoma not remission is primarily caused by the dysregulation of T-cells in response to chronic intestinal inflammation, often linked to conditions like celiac disease. The disease can progress rapidly, leading to significant morbidity and necessitating urgent medical intervention.
ICD-10 Code C86.20 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans for Enteropathy-type (intestinal) T-cell lymphoma not remission. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's clinical status.
In SOAP notes, ICD-10 Code C86.20 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Enteropathy-type (intestinal) T-cell lymphoma not remission. This coding supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.
The management of Enteropathy-type (intestinal) T-cell lymphoma not remission often requires hospitalization due to its aggressive nature. Treatment may include chemotherapy and supportive care to manage symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.20 is critical for billing purposes in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C86.20 for Enteropathy-type (intestinal) T-cell lymphoma not remission
What are the common symptoms of Enteropathy-type T-cell lymphoma?
Common symptoms include chronic diarrhea, weight loss, abdominal pain, and signs of malabsorption. Patients may also experience fatigue and nutritional deficiencies due to the disease's impact on the gastrointestinal tract.
How is Enteropathy-type T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of intestinal tissue to confirm the presence of T-cell lymphoma. Laboratory tests may also be conducted to assess nutritional status and rule out other conditions.
What treatment options are available for Enteropathy-type T-cell lymphoma?
Treatment often includes chemotherapy, and in some cases, stem cell transplantation may be considered. Supportive care to manage symptoms and nutritional support are also critical components of the treatment plan.
Is Enteropathy-type T-cell lymphoma curable?
The prognosis for Enteropathy-type T-cell lymphoma varies based on the stage at diagnosis and response to treatment. While some patients may achieve remission, others may experience recurrence, necessitating ongoing management.
Clinical Notes
SOAP notes
DAP notes
AI medical notes